尖峰集团：富马酸伏诺拉生化学原料药获批上市

Group 1 - The core point of the article is that Jianfeng Group's subsidiary, Anhui Jianfeng Beika Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug, Fumaric Acid Venlafaxine, which is used to treat gastroesophageal reflux disease as a potassium ion competitive acid blocker [1] Group 2 - Fumaric Acid Venlafaxine is specifically indicated for the treatment of gastroesophageal reflux disease [1] - The approval signifies a potential growth opportunity for Jianfeng Group in the pharmaceutical market [1]